格隆汇8月1日丨博拓生物(688767.SH)在互动平台表示，公司传染病检测系列包含针对基孔肯雅热等热 带传染病的检测试剂。该产品在境外部分市场可以进行销售，未对公司当前收入及利润产生重大影响。 国内市场尚未取得基孔肯雅热相关医疗器械注册证，目前仅作为科研试剂适用于海关、疾控等应用场景 的检测需求。公司在国内已取得蚊媒类传染病注册证书的产品有登革抗原检测试剂（胶体金法）、恶性 疟原虫富组氨酸蛋白Ⅱ（HRP-Ⅱ）抗原检测试剂（胶体金法）。 ...

Group 1 - The assisted reproductive industry is experiencing a strong upward trend, with companies such as HanShang Group, FuYuan Pharmaceutical, and LiDeMan reaching their daily price limit [1] - Other companies in the sector, including GongTong Pharmaceutical, DaJia WeiKang, SiChuang YiHui, BoTuo Bio, BeiRui Gene, and MaiDi Technology, also saw significant increases in their stock prices [1]

注：已剔除近一年上市新股。本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） | 代码 | 简称 | 今日涨跌 | 今日换手 | 5日均线 | 10日均线 | 5日较10日均线 | 最新价 | 较10日均线乖 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | （%） | 率（%） | （元） | （元） | 距离（%） | （元） | 离率（%） | | 600819 | 耀皮 | -3.08 | 2.49 | 6.56 | 6.65 | -1.26 | 6.30 | -5.23 | | | 玻璃 | | | | | | | | | 688767 | 博拓 生物 | 1.65 | 2.69 | 33.60 | 33.99 | -1.16 | 32.10 | -5.57 | | 002350 | 北京 | -1.14 | 2.90 | 7.10 | 7.18 | -1.07 | 6.91 | -3.77 | | | 科锐 | | | | | | | | | 600113 | 浙江 东日 | 5.31 | ...

Market Overview - As of 10:29 AM, the Shanghai Composite Index is at 3583.25 points, with a decline of 0.90% [1] - The total trading volume of A-shares today is 842.95 billion yuan [1] Technical Analysis - A total of 82 A-shares have seen their 5-day moving average cross below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Zhejiang Dongri: 5-day MA at 28.41 yuan, 10-day MA at 28.80 yuan, difference of -1.37% [1] - Yaopi Glass: 5-day MA at 6.58 yuan, 10-day MA at 6.66 yuan, difference of -1.14% [1] - Botao Bio: 5-day MA at 33.61 yuan, 10-day MA at 34.00 yuan, difference of -1.14% [1] Individual Stock Performance - Zhejiang Dongri (600113): Today's change is +1.78%, with a turnover rate of 0.86% [1] - Yaopi Glass (600819): Today's change is -1.85%, with a turnover rate of 0.80% [1] - Botao Bio (688767): Today's change is +1.90%, with a turnover rate of 1.08% [1] - Beijing Keri (002350): Today's change is -0.57%, with a turnover rate of 0.91% [1] - Dayou Energy (600403): Today's change is -2.81%, with a turnover rate of 0.56% [1] Additional Stocks with Moving Average Cross - Other stocks experiencing a similar trend include: - Sanor (300298): Today's change is -0.94%, with a turnover rate of 0.99% [1] - Iceberg Cold and Hot (000530): Today's change is +1.11%, with a turnover rate of 2.61% [1] - Yashi Chuangneng (603378): Today's change is -1.31%, with a turnover rate of 0.55% [1] - Guotian Group (002482): Today's change is -2.21%, with a turnover rate of 0.62% [1]

Group 1 - The fentanyl concept index declined by 0.88%, ranking among the top declines in the concept sector as of July 29 [1] - Within the fentanyl sector, companies such as Botao Bio, Enhua Pharmaceutical, and Wanfu Bio experienced significant declines, while three companies, including China National Pharmaceutical Modern, Lingrui Pharmaceutical, and Renfu Pharmaceutical, saw slight increases of 1.07%, 0.17%, and 0.09% respectively [1] Group 2 - The fentanyl concept sector experienced a net outflow of 80 million yuan in capital today, with six stocks seeing net outflows, and five stocks with outflows exceeding 10 million yuan [2] - Renfu Pharmaceutical had the highest net outflow of 18.1651 million yuan, followed by Dongfang Bio, Enhua Pharmaceutical, and Wanfu Bio with net outflows of 16.8542 million yuan, 16.6752 million yuan, and 15.9620 million yuan respectively [2] - The top net inflow stocks in the fentanyl concept sector included China National Pharmaceutical Modern and China National Pharmaceutical, with net inflows of 9.5225 million yuan and 1.2608 million yuan respectively [2]

Group 1 - The core viewpoint of the news highlights a significant rise in virus prevention stocks, particularly in response to the reported cases of Chikungunya fever in Foshan, Guangdong Province [1][2][3] - Notable stock performances include Zhifei Biological, which increased by 16.86%, and Watson Bio, which rose by 13.39%, among others [2] - The total market capitalization of Zhifei Biological is reported at 57.7 billion, while Watson Bio stands at 21 billion [2] Group 2 - As of July 22, Foshan has reported a total of 3,195 confirmed cases of Chikungunya fever, primarily concentrated in the Shunde District [2] - The World Health Organization has issued a warning regarding mosquito-borne diseases, urging countries to prepare for potential outbreaks [3]

Summary of Key Points Core Viewpoint - The financing balance of the Sci-Tech Innovation Board (STAR Market) has increased, indicating a growing interest in investments within this sector, with a total balance of 158.34 billion yuan as of July 1, reflecting a continuous increase over the past seven trading days [1]. Financing Balance - As of July 1, the total financing balance on the STAR Market reached 157.77 billion yuan, an increase of 6.26 million yuan from the previous trading day [1]. - The stock with the highest financing balance is SMIC, with a latest balance of 7.12 billion yuan, followed by Cambrian and Haiguang Information with balances of 4.50 billion yuan and 3.65 billion yuan respectively [1]. - A total of 315 stocks saw an increase in financing balance, while 269 stocks experienced a decrease [1]. - Notable increases in financing balance were observed in Xiangyu Medical (66.24%), Botao Bio (43.29%), and Nanmo Bio (31.08%) [1]. Securities Lending Balance - The total securities lending balance on the STAR Market reached 5.65 billion yuan, with an increase of 8.89 million yuan from the previous trading day [1]. - SMIC also leads in securities lending balance with 20 million yuan, followed by Haiguang Information and Chipone Technology, both at 16 million yuan [2]. - A total of 137 stocks saw an increase in securities lending balance, while 133 stocks experienced a decrease [2]. - Significant increases in securities lending balance were noted for Diao Micro (59.14%), Huahai Qingke (56.71%), and China Shipbuilding Gas (53.60%) [2].

Group 1 - The company has completed the registration of business changes and obtained a new business license from the Zhejiang Provincial Market Supervision Administration [2] - The company held its 2024 annual general meeting on May 16, 2025, where it approved the profit distribution and capital reserve conversion plan for 2024, which was implemented on June 6, 2025 [1] - The company held its second extraordinary general meeting of 2025 on June 4, 2025, where it approved the cancellation of the supervisory board, expansion of business scope, and amendments to the articles of association [2] Group 2 - The company's registered capital is 149,333,334 yuan, and its business scope includes various technical services, medical device sales, and electronic component manufacturing [2] - The company is classified as a listed other joint-stock company with a unified social credit code of 9133010079969193XF [2] - The company’s business activities encompass a wide range of sectors, including technology development, medical equipment, and electronic products [2]

股票代码：688767 证券简称：博拓生物 公告编号：2025-035 杭州博拓生物科技股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 杭州博拓生物科技股份有限公司（以下简称"公司"）于2025年5月16日召开2024 年年度股东大会，审议通过了《关于2024年年度利润分配及资本公积转增股本预案的议 案》，权益分派已于2025年6月6日实施完毕。具体内容详见公司于2025年5月30日在上 海证券交易所网站（www.sse.com.cn）披露的《杭州博拓生物科技股份有限公司2024 年年度权益分派实施公告》（公告编号：2025-031）。 1 产租赁；园区管理服务；货物进出口；技术进出口；工程和技术研究和试验发展；计算 机软硬件及外围设备制造；信息技术咨询服务；电子真空器件制造；信息安全设备销售； 电子元器件零售；电子真空器件销售；电力电子元器件销售；信息安全设备制造；第二 类医疗设备租赁；计算器设备销售；电力电子元器件制造；电子元器件制造；电子专用 材料制造；集成电路 ...

Group 1 - A total of 24 companies were investigated by institutions on June 25, with 17 companies specifically targeted by funds [1][2] - The most popular company among funds was Botao Bio, which had 21 participating funds, followed by Sanfu Outdoor and Entropy Technology with 7 and 6 funds respectively [1][2] - The companies investigated belong to 12 different industries, with the textile and apparel, and pharmaceutical and biotechnology sectors having the most companies, each with 3 stocks listed [1] Group 2 - Among the companies investigated, 3 had a total market capitalization exceeding 50 billion yuan, while 13 had a market cap below 10 billion yuan [1] - In terms of market performance, 9 stocks among the investigated companies saw an increase in the last 5 days, with Haike Xinyuan, Bai'ao Intelligent, and Ganfeng Lithium leading with increases of 50.83%, 10.42%, and 5.88% respectively [1][2] - Conversely, 8 stocks experienced declines, with Mankalon, Botao Bio, and China Merchants Energy showing the largest drops of 7.94%, 5.35%, and 4.76% respectively [1][2]